MEA Genomic Testing Market

MEA Genomic Testing Market size was valued at USD 0.5 billion in 2025 and is forecast to grow from USD 0.6 billion in 2026 to reach USD 1.1 billion by 2031, at a CAGR of 17.8%.

Description

The Middle East & Africa Genomic Testing Market size was valued at USD 0.5 billion in 2025 and is forecast to grow from USD 0.6 billion in 2026 to reach USD 1.1 billion by 2031, at a CAGR of 17.8%. Genomic testing encompasses predictive and presymptomatic testing, carrier screening, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing delivered through next-generation sequencing, PCR-based, and microarray technologies, ranging from single-gene disorder screening to comprehensive whole-genome and whole-exome sequencing panels. The market sits at the intersection of precision medicine, molecular diagnostics, and national genomics research initiatives, making it one of the most rapidly expanding technology categories across the regional healthcare services value chain.

Demand for genomic testing services remains anchored by rising prevalence of genetic and hereditary disorders, growing government investment in national genome sequencing programs, and expanding adoption of personalized and precision medicine across Saudi Arabia, the United Arab Emirates, Israel, South Africa, and Egypt. Beyond diagnostic testing, genomic testing platforms continue to enable applications in reproductive health screening, oncology biomarker profiling, and drug response prediction that require accurate, comprehensive molecular testing solutions. Increasing investment in sequencing technology infrastructure, expanding national genome mapping initiatives, and continued integration with electronic health record and clinical decision-support platforms are sustaining growth even as the region transitions toward more precision-driven, technology-enabled diagnostic delivery models.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Middle East & Africa Genomic Testing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Test Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Others)

      2. By Technology (Next-Generation Sequencing (NGS), PCR-Based Testing, Microarray, Others)

      3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, Others)

      4. By Country

      5. By Company (2025)

  • Saudi Arabia Genomic Testing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Test Type

      2. By Technology

      3. By End User

  • United Arab Emirates Genomic Testing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Test Type

      2. By Technology

      3. By End User

  • Israel Genomic Testing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Test Type

      2. By Technology

      3. By End User

  • South Africa Genomic Testing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Test Type

      2. By Technology

      3. By End User

  • Egypt Genomic Testing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Test Type

      2. By Technology

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Middle East & Africa Genomic Testing Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Illumina Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Thermo Fisher Scientific Inc.

    3. QIAGEN N.V.

    4. Centogene N.V.

    5. G42 Healthcare

    6. Roche Diagnostics

    7. BGI Genomics

    8. Natera Inc.

    9. Saudi Human Genome Program

    10. Dante Labs

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology